The role of ATG in reducing acute GvHD in related and unrelated donor transplants

被引：0
|
作者：
Zalyalov, Y [1 ]
Ganapiev, A [1 ]
Alexeev, S [1 ]
Smirnova, A [1 ]
Stancheva, N [1 ]
Ivanova, N [1 ]
Alyanskiy, A [1 ]
Afanasyev, B [1 ]
机构：
[1] Pavlovs State Med Univ, St Petersburg, Russia
来源：
BONE MARROW TRANSPLANTATION | 2006年 / 37卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [41] Considerations for haploidentical versus unrelated donor transplants
    Stefan O. Ciurea
    Bone Marrow Transplantation, 2019, 54 : 738 - 742
  • [42] Low rates of acute/chronic GVHD using combination of ATG and PTCy as GVHD prophylaxis in MUD transplants for hematological malignancies - a single centre experience
    Sudha, Shruti Prem
    Law, Arjun
    Lam, Wilson
    Thyagu, Santhosh
    Michelis, Fotios
    Kim, Dennis
    Lipton, Jeffrey
    Messner, Hans
    Viswabandya, Auro
    BONE MARROW TRANSPLANTATION, 2018, 53 : 432 - 433
  • [43] Anti-thymocyte globulin as part of the conditioning regimen for recipients of unrelated donor transplants:: comparison of ATG Fresenius and thymoglobulin
    Zander, AR
    Remberger, M
    Kroger, N
    Mattson, J
    Zabelina, T
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2005, 35 : S42 - S42
  • [44] Related or unrelated donor
    Hansen, John A.
    BLOOD, 2012, 119 (10) : 2183 - 2184
  • [45] Continuous infusion cyclosporine and nifedipine to day+100 with short methotrexate and steroids as GVHD prophylaxis in unrelated donor transplants
    Liesveld, JL
    Duerst, RE
    Rapoport, AP
    Constine, LS
    Abboud, CN
    Packman, CH
    Wedow, LA
    Zwetsch, L
    McKenna, B
    Linder, T
    Silverman, WA
    Swift, SB
    Rowe, JM
    DiPersio, JF
    BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 511 - 516
  • [46] Post Transplant Cyclophosphamide (PTCy) with Anti-Thymocyte Globulin (ATG) Effectively Reduces the Severe (Grade III-IV) Acute Graft-Versus-Host Disease (GVHD) When Compared to ATG Alone in Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplants
    Deotare, Uday
    Loach, David
    Michelis, Frank
    Kim, Dennis
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans
    Viswabandya, Auro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S315 - S315
  • [47] Matched unrelated donor transplantation without ATG: does the use of PBSC increase chronic GVHD? A single-centre experience
    Marenco, P.
    Grillo, G.
    Mancini, V.
    Bertani, G.
    Brasca, P.
    Morra, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S413 - S413
  • [48] COMPARISON BETWEEN POSTTRANSPLANT CYCLOPHOSPAMIDE AND ATG BASED REGIMENS AS GVHD PROPYLAXIS IN ONE-ANTIGEN MISMATCH UNRELATED DONOR TRANSPLANTATION
    Facchin, Gabriele
    Battista, Marta Lisa
    De Martino, Maria
    Isola, Miriam
    Geromin, Antonella
    Savignano, Chiara
    Simeon, Valentina
    Soravia, Alessandra
    Di Renzo, Giuseppe
    Pizzano, Umberto
    Pucillo, Martina
    Fanin, Renato
    Patriarca, Francesca
    BONE MARROW TRANSPLANTATION, 2024, 59 : 300 - 300
  • [49] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    Kharfan-Dabaja, M. A.
    Parody, R.
    Perkins, J.
    Lopez-Godino, O.
    Lopez-Corral, L.
    Vazquez, L.
    Caballero, D.
    Falantes, J.
    Shapiro, J.
    Orti, G.
    Barba, P.
    Valcarcel, D.
    Esquirol, A.
    Martino, R.
    Pinana, J. L.
    Solano, C.
    Tsalatsanis, A.
    Pidala, J.
    Anasetti, C.
    Perez-Simon, J. A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (03) : 438 - 444
  • [50] Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation
    M A Kharfan-Dabaja
    R Parody
    J Perkins
    O Lopez-Godino
    L Lopez-Corral
    L Vazquez
    D Caballero
    J Falantes
    J Shapiro
    G Ortí
    P Barba
    D Valcárcel
    A Esquirol
    R Martino
    J L Piñana
    C Solano
    A Tsalatsanis
    J Pidala
    C Anasetti
    J A Perez-Simón
    Bone Marrow Transplantation, 2017, 52 : 438 - 444
12345